Drugs for Plasmodium Falciparum Malaria (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 105)
| # |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
| 1 |
|
Dapsone |
Approved, Investigational |
Phase 4 |
|
80-08-0 |
2955 |
|
Synonyms:
(4-sulfanilylphenyl)amine
1,1'-sulfonylbis(4-aminobenzene)
1,1'-Sulfonylbis(4-aminobenzene)
1,1'-Sulfonylbis[4-aminobenzene]
1,1'-Sulphonylbis(4-aminobenzene)
1358F
32960_FLUKA
4-(4-amino-benzenesulfonyl)-phenylamine
4-(4-Amino-benzenesulfonyl)-phenylamine
4-(4-Amino-benzenesulphonyl)-phenylamine
4-(4-aminophenyl)sulfonylaniline
4-(4-aminophenylsulfonyl)aniline
4-(4-Aminophenylsulfonyl)aniline
4-(4-aminophenylsulfonyl)benzenamine
4-(4-Aminophenylsulfonyl)benzenamine
4-(4-Aminophenylsulphonyl)aniline
4-(4-Aminophenylsulphonyl)benzenamine
4,4' Diaminophenyl sulfone
4,4' Diaminophenyl Sulfone
4,4'-dapsone
4,4'-Dapsone
4,4-Diaminodifenylsulfon
4,4-Diaminodifenylsulfon [Czech]
4,4'-diaminodiphenyl sulfone
4,4'-Diaminodiphenyl sulfone
4,4'-Diaminodiphenyl sulphone
4,4'-Diaminodiphenyl suphone
4,4'-Diaminodiphenylsulfone
4,4'-diaminophenyl sulfone
4,4'-Diaminophenyl sulfone
4,4'-sulfonylbisaniline
4,4'-Sulfonylbisaniline
4,4'-Sulfonylbisbenzamine
4,4'-Sulfonylbisbenzenamine
4,4'-Sulfonylbisbenzeneamine
4,4'-Sulfonyldianilin
4,4'-sulfonyldianiline
4,4'-Sulfonyldianiline
4,4-Sulfonyldianiline
4,4'-Sulfonyldianiline (Dapsone)
4,4'-Sulphonylbisaniline
4,4'-Sulphonylbisbenzamine
4,4'-Sulphonylbisbenzenamine
4,4'-Sulphonyldianiline
4-[(4-aminobenzene)sulfonyl]aniline
4-[(4-aminophenyl)sulfonyl]aniline
46158_FLUKA
46158_RIEDEL
4-Aminop henyl sulfone
4-aminophenyl sulfone
4-Aminophenyl sulfone
4-Aminophenyl sulphone
4-Aminophenylsulfone
80-08-0
A74807_ALDRICH
AB00051962
AB1004833
AC-10922
AC1L1EUH
AC1Q51WM
AC1Q51WN
Acedapsone
Aczone
Aczone (TN)
AI3-08087
AKOS000119322
ALBB-005917
Ambap80-08-0
Araldite Ht
Araldite HT
Araldite HT 976
Atrisone
Avlosulfon
Avlosulfone
Avlosulphone
Avsulfor
AZT + Dapsone cominbation
BIDD:GT0770
Bis(4-aminophenyl) sulfone
bis(4-aminophenyl)sulfone
Bis(4-aminophenyl)sulfone
Bis(4-aminophenyl)sulphone
Bis(p-aminophenyl) sulfone
Bis(p-aminophenyl) sulphone
Bis(p-aminophenyl)sulphone
BPBio1_000143
BRD-K62363391-001-05-8
BRN 0788055
BSPBio_000129
BSPBio_002129
C07666
CAS-80-08-0
CBDivE_013582
CCRIS 192
CHEBI:4325
CHEMBL1043
CID2955
CPD000059064
Croysulfone
Croysulphone
D SS
D003622
D00592
D0089
DADPS
Dapsoderm-X
Dapson
Dapsona
Dapsona [INN-Spanish]
dapsone
Dapsone
Dapsone (USP)
Dapsone [USAN:BAN]
Dapson-fatol
Dapson-Fatol
Dapsonum
Dapsonum [INN-Latin]
DB00250
DDS
DDS (pharmaceutical)
Dds, Diaphenylsulfone
DDS, diaphenylsulfone
Dds, Pharmaceutical
DDS, pharmaceutical
DDS, Pharmaceutical
Di(4-aminophenyl) sulfone
Di(4-aminophenyl)sulfone
Di(4-aminophenyl)sulphone
Di(p-aminophenyl) sulfone
Di(p-aminophenyl)sulphone
Diamino-4,4'-diphenyl sulfone
Diamino-4,4'-diphenyl sulphone
Diaminodifenilsulfona
Diaminodifenilsulfona [Spanish]
Diaminodiphenyl sulfone
Diaminodiphenyl Sulfone
Diamino-diphenyl sulphone
Diaminodiphenylsulfone
Diaphenylsulfon
|
Diaphenylsulfone
DIAPHENYLsulfone
Diaphenylsulfone (JAN)
Diaphenylsulphon
Diaphenylsulphone
DIAPHENYLsulphone
Dimitone
Diphenasone
Diphone
Disulone
DivK1c_000573
DSS
DSS (VAN)
Dubronax
Dubronaz
Dumitone
EINECS 201-248-4
Eporal
F 1358
Fatol brand OF dapsone
Fatol Brand of Dapsone
Hardener HT 976
HMS1568G11
HMS1920C14
HMS2091K04
HMS501M15
HSDB 5073
HT 976
HY 976
I01-3640
ICI
IDI1_000573
IN-201
KBio1_000573
KBio2_001368
KBio2_003936
KBio2_006504
KBio3_001349
KBioGR_000900
KBioSS_001368
LS-1790
Metabolite C
Mex-america brand OF dapsone
Mex-America Brand of Dapsone
MLS000069409
MLS001055349
MLS001076146
MolPort-001-780-172
N, N'-Diphenyl sulfondiamide
N, N'-Diphenyl Sulfondiamide
N,N'-Diphenyl sulfondiamide
NCGC00016322-01
NCGC00016322-02
NCGC00023946-03
NCGC00023946-04
NCGC00023946-05
NCGC00023946-06
NCI-C01718
NINDS_000573
Normet
Novophone
NSC 6091
NSC 6091D
NSC6091
NSC-6091
Oprea1_143052
Orsade brand OF dapsone
Orsade Brand of Dapsone
p, p'-Sulfonyldianiline
P, P'-Sulfonyldianiline
p,p'-diaminodiphenyl sulfone
p,p'-Diaminodiphenyl sulfone
p,P'-diaminodiphenyl sulfone
P,P'-Diaminodiphenyl Sulfone
p,p-Diaminodiphenyl sulphone
p,P'-diaminodiphenyl sulphone
P,P-Diaminodiphenyl Sulphone
p,p-Sulfonylbisbenzamine
P,P-Sulfonylbisbenzamine
p,p-Sulfonylbisbenzenamine
P,P-Sulfonylbisbenzenamine
p,p'-sulfonyldianiline
p,p-sulphonylbisbenzamine
p,p-Sulphonylbisbenzamine
P,P-Sulphonylbisbenzamine
p,p-sulphonylbisbenzenamine
p,p-Sulphonylbisbenzenamine
P,P-Sulphonylbisbenzenamine
p,p-Sulphonyldianiline
P,P-Sulphonyldianiline
p-aminophenyl sulfone
p-Aminophenyl sulfone
P-Aminophenyl Sulfone
p-Aminophenyl sulphone
Prestwick_152
Prestwick0_000035
Prestwick1_000035
Prestwick2_000035
Prestwick3_000035
Protogen
Recolip
SAM002554879
SMR000059064
SPBio_001025
SPBio_002050
Spectrum_000888
SPECTRUM1500222
Spectrum2_001133
Spectrum3_000375
Spectrum4_000310
Spectrum5_000825
STK387118
Sulfadione
Sulfanona-mae
Sulfanona-Mae
Sulfona
Sulfona-Mae
Sulfona-MAE
Sulfone ucb
Sulfone Ucb
Sulfone, 4,4'-diaminophenyl
Sulfone, 4,4'-Diaminophenyl
Sulfon-mere
Sulfon-Mere
Sulfonyldianiline
Sulphadione
Sulphon-mere
Sulphon-Mere
Sulphonyldianiline
Sumicure S
Tarimyl
TL8005401
Udolac
UNII-8W5C518302
W R 448
WLN: ZR DSWR DZ
WR 448
ZINC00006310
|
|
| 2 |
|
Quinine |
Approved |
Phase 4 |
|
130-95-0 |
8549 3034034 |
|
Synonyms:
(−)-quinine
(-)-Quinine
(+)-Quinidine
(1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol
(3|A,8|A,9r)-6'-methoxycinchonan-9-ol
(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol
(8.alpha.,9R)-6'-Methoxycinchonan-9-ol
(8-alpha,9R)-6'-Methoxycinchonan-9-ol
(8S,9R)-6'-Methoxycinchonan-9-ol
(8S,9R)-quinine
(8S,9R)-Quinine
(9R)-6'-methoxy-8alpha-cinchonan-9-ol
(R)-(-)-quinine
(R)-(−)-quinine
(R)-(-)-Quinine
(R)-(-)-Quinine, 6-methoxycinchonidine
(R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol
(R)-(6-Methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol
(R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol
(R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
(R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
(S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol
(S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
.alpha.-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol
12239-42-8
128544-03-6
130-89-2
130-95-0
1407-83-6
145904_ALDRICH
21480-31-9
22620_FLUKA
22620_SIGMA
549-56-4
55980-20-6
56-54-2
6119-70-6
6183-68-2
6912-57-8
6'-Methoxycinchonan-9-ol
6'-Methoxycinchonidine
6'-Methoxycinchonine
6-Methoxycinchonine
72646-90-3
767303-40-2
804-63-7
840482-04-4
857212-53-4
864908-93-0
875538-34-4
888714-03-2
890027-24-4
894767-09-0
898813-59-7
898814-28-3
899813-83-3
900786-66-5
900789-95-9
906550-97-8
909263-47-4
909767-48-2
909882-78-6
910878-25-0
910880-97-6
911445-75-5
918778-04-8
AC1L1ANE
AC1L1R7Y
AC1L9AHT
AC1LCUGN
AC1MHWS7
AC1MI1Q5
AC1Q4EZ5
AC1Q58AF
Aflukin
Alphapharm brand OF quinine sulfate
AR-1A4833
AR-1H2065
Aventis brand OF quinine bisulfate
BB_NC-0697
beta-Quinine
Biquinate
Biquinate (*Bisulfate heptathydrate*)
Bisulfate, quinine
C06526
C20H24N2O2
CCRIS 5755
CHEBI:111177
CHEBI:15854
CHEMBL170
CHEMBL97
Chinin
Chinin [German]
Chinine
chininum
Chininum
CID1065
CID3034034
CID3036746
CID441073
CID637552
CID8549
Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate
Cin-Quin
Coco-Quinine
Conchinin
|
Conquinine
D08460
DB00468
Dentojel (*Bisulfate heptathydrate*)
EINECS 205-003-2
EINECS 215-805-4
Fawns and mcallan brand OF quinine bisulfate
Fawns and mcallan brand OF quinine sulfate
Foy brand OF quinine sulfate
HMS1607A11
HMS1791J11
HMS2089E05
Hoechst brand OF quinine sulfate
HSDB 2501
Hydrochloride, quinine
I14-3348
I14-3397
IBS-L0034250
InChI=1/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H
Innotech brand OF quinine hydrochloride
Kinder Quinina
Kinder Quinina (TN)
KST-1A1085
L001278
Lafran brand OF quinine hydrochloride
Legatrim
Lopac0_001029
LS-141252
LS-194958
LS-4562
LT00645788
MLS001304041
MolPort-000-146-082
MolPort-001-766-747
MolPort-002-507-196
MolPort-003-901-021
Myoquin
NCGC00015871-03
NCGC00142453-01
NCGC00159499-02
NCGC00159499-03
NCGC00162322-01
NCGC00162322-02
NCGC00163142-03
NCGC00166281-01
nchem.1039-compI
nchem.180-comp1a
nchembio.215-comp5
nchembio.368-comp9
nchembio.87-comp19
NCI60_004320
NSC 192949
NSC 5362
NSC131458
NSC192949
NSC5362
NSC667852
Odan brand OF quinine sulfate
Plough brand OF quinine sulfate
Prosana brand OF quinine bisulfate
Q0028
Quinamm
Quinamm (*2:1 Sulfate salt*), dihydrate
Quinbisan
Quinbisul
Quindan
Quine (*2:1 Sulfate salt*, dihydrate)
Quinidex
quinidine
Quinimax
quinina
Quinina
Quinine
Quinine (BAN)
Quinine [BAN]
Quinine anhydrous
Quinine bisulfate
Quinine Dab
Quinine hydrochloride
Quinine lafran
QUININE MONO HCL
quinine sulfate
Quinine sulfate
Quinine sulphate
Quinine, anhydrous
Quinine, Anhydrous
Quinine, polymers
Quinine, tannate
Quinineanhydrous
Quinine-odan
Quinoctal
Quinoline alkaloid
Quinoline Alkaloid
Quinora
Quinsan (*2:1 Sulfate salt*), dihydrate
Quinson
Quinsul
Quniacridine
SB01652
SMR000718748
ST056282
Strema
Sulfate, quinine
Sulphate, quinine
Surquina
UNII-A7V27PHC7A
WLN: T66 BNJ HO1 EYQ-DT66 A B CNTJ A1U1
|
|
| 3 |
|
Nevirapine |
Approved |
Phase 4 |
|
129618-40-2 |
4463 |
|
Synonyms:
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one & PRO 140 (Anti-CCR5 monoclonal antibody)
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one
11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one
11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE
129618-40-2
1vrt
2hny
AC1L1I81
AC-643
BI RG 587
BIDD:GT0326
Bio-0789
BIRG 0587
BIRG 587
BIRG-0587
BIRG587
BIRG-587
BI-RG-587
BI-RG-587 & CD4-IgG
C07263
C15H14N4O
Cahill May Roberts Brand of Nevirapine
CHEBI:44659
CHEMBL57
CID4463
CPD000048458
D00435
D019829
DB00238
DB08311
Hemihydrate, nevirapine
HMS2051J09
HSDB 7164
|
I02-0310
LS-2289
MLS000084585
MLS000759409
MLS001055309
MLS001201730
MolPort-002-507-817
N11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one & CD4-immunoadhesin
NCGC00065890-02
NEV
Nevirapina
nevirapine
Nevirapine
Nevirapine & CD4-IgG
Nevirapine & PRO 140
Nevirapine (JAN/USP/INN)
Nevirapine [USAN:INN]
Nevirapine anhydrous
Nevirapine hemihydrate
Nevirapine, anhydrous
NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE
NSC 641530
NSC641530
NVP
Promeco Brand of Nevirapine
S1742_Selleck
SAM001246551
SMR000048458
STK580320
UNII-99DK7FVK1H
Viramune
Viramune (TN)
Viramune(TM)
Viramune, BI-RG 587, Nevirapine
ZINC00004778
|
|
| 4 |
|
Lactitol |
Approved, Investigational |
Phase 4 |
|
585-86-4 |
157355 |
|
Synonyms:
4-O-beta-D-Galactopyranosyl-D-glucitol
4-O-Î’-D-galactopyranosyl-D-glucitol
D-Lactitol
Emportal
Importal
|
Lactitol
Lactitolum
Neda lactiv importal
Oponaf
|
|
| 5 |
|
Efavirenz |
Approved, Investigational |
Phase 4 |
|
154598-52-4 |
64139 |
|
Synonyms:
(-)-6-CHLORO-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
(-)-Efavirenz
(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
(4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
(S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben
(S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-(S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
(S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[D][1,3]oxazin-2-one
154598-52-4
1ikv
1ikw
2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)- (9
6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one
6-Chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[D][1,3]oxazin-2-one
AC-19049
AC1L20IX
BIDD:GT0383
Bristol-myers squibb brand OF efavirenz
C08088
C14H9ClF3NO2
CHEBI:119486
CHEMBL223228
CID64139
CPD000466351
D00896
DB00625
DB07709
DMP 266
DMP-266
Du pont brand OF efavirenz
efavirenz
Efavirenz
|
Éfavirenz
Efavirenz (JAN/INN)
Efavirenz, (R)-isomer
efavirenz, (S)-isomer
Efavirenz, (S)-isomer
Efavirenzum
EFV
EFZ
Eravirenz
HMS2051J08
HMS2090N16
HSDB 7163
L 743726
L-741211
L-743,726
L-743725
L-743726
LS-173464
Merck sharp and dohme brand OF efavirenz
Met-SDF-1.beta. & Efavirenz
Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz
MLS000759465
MLS001424087
MolPort-003-983-924
NSC742403
SAM001246667
SBB066062
SMR000466351
Stocrin
Strocin (TM)
Sustiva
Sustiva (TM)
Sustiva (TN)
UNII-JE6H2O27P8
United drug brand OF efavirenz
ZINC02020233
zoxazin-2-one
|
|
| 6 |
|
Primaquine |
Approved |
Phase 4 |
|
90-34-6 |
4908 |
|
Synonyms:
(-)-N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine
()-Primaquine
(-)-Primaquine
(+)-N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine
(+)-Primaquine
(+/-)-Primaquine
1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)- (9CI)
4-22-00-05817 (Beilstein Handbook Reference)
4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine
63-45-6
63-45-6 (1:2 PO4)
6-Methoxy-8-(4-amino-1-methylbutylamino)quinoline
6-Methoxy-8-[(4-amino-1-methylbutyl)amino]quinoline
6-Methoxy-8-[4-amino-1-methylbutylamino]quinoline
8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline
8-(4-Amino-1-m
8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline
8-[(4-Amino-1-methylbutyl)amino]-6-methoxyquinoline
90-34-6
AB00053529
AC1L1J80
AC1Q4F0C
AC1Q4F4Q
Boucher and muir brand OF primaquine phosphate
BPBio1_000674
BRN 0019337
BSPBio_000612
BSPBio_002223
C07627
CCRIS 4109
CHEBI:8405
CHEMBL506
CID4908
D08420
DB01087
Diphosphate, primaquine
DivK1c_000806
dl-Primaquine
EINECS 201-987-2
ethylbutylamino)-6-methoxyquinoline
HMS2090J17
HSDB 6516
I08-0048
IDI1_000806
Kanaprim
Kanaprim (TN)
KBio1_000806
KBio2_001310
KBio2_003878
KBio2_006446
KBio3_001723
KBioGR_000967
KBioSS_001310
LS-141312
MolPort-001-794-628
N(4)-(6-methoxyquinolin-8-yl)pentane-1,4-diamine
|
N-(5-aminopentan-2-yl)-6-methoxyquinolin-8-amine
N~4~-[6-(methyloxy)quinolin-8-yl]pentane-1,4-diamine
N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine
NCGC00178754-01
NCGC00178754-02
NCI60_001035
NCI60_005887
Neo-quipenyl
Neo-Quipenyl
NINDS_000806
NSC 27296
NSC27296
Oprea1_546209
Phosphate, primaquine
PQ
Prestwick0_000476
Prestwick1_000476
Prestwick2_000476
Prestwick3_000476
Primachin
Primachina
Primachina [DCIT]
Primachinum
Primacin
Primaquin
Primaquina
Primaquina [INN-Spanish]
Primaquine
PRIMAQUINE
Primaquine (INN)
Primaquine [INN:BAN]
Primaquine Bis-Phosphoric Acid
Primaquine diphosphate
Primaquine phosphate
Primaquinum
Primaquinum [INN-Latin]
Quinoline, 8-(4-amino-1-methylbutylamino)-6-methoxy
Quinoline, 8-[(4-amino-1-methylbutyl)amino]-6-methoxy- (6CI,8CI)
S. N. 13272
SMP1_000263
SN 13,272
SN 13272
SPBio_000674
SPBio_002551
Spectrum_000830
Spectrum2_000887
Spectrum3_000552
Spectrum4_000484
Spectrum5_001363
STOCK5S-90838
TG1-296
TG1-297
UNII-MVR3634GX1
WLN: T66 BNJ HO1 JMY1&3Z
WR 2975
|
|
| 7 |
|
chloroquine |
Approved, Investigational, Vet_approved |
Phase 4 |
|
54-05-7 |
2719 |
|
Synonyms:
( -)-Chloroquine
(-)-Chloroquine
(+)-Chloroquine
(R)-(-)-Chloroquine
{4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine
3377 RP opalate
3545-67-3
50-63-5
54-05-7
56598-66-4
58175-86-3
58175-87-4
7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline
7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline
AB00053436
AC1L1EB8
AC1Q2ZA7
AC1Q2ZA8
Amokin
Aralen
Aralen HCl
Arechin
Arechine
Arequin
Arolen
Arthrochin
Artrichin
Avlochlor
Avloclor
Bemaco
Bemaphate
Bemaphic acid
Bemasulph
Benaquin
Bipiquin
BPBio1_000655
BRD-A91699651-065-01-1
BRN 0482809
BSPBio_000595
BSPBio_002001
C07625
C18H26ClN3
Capquin
CCRIS 3439
CHEBI:3638
CHEMBL76
Chemochin
Chingamin
Chloraquine
Chlorochin
Chlorochine
Chlorochinum
Chloroin
Chloroquin
Chloroquina
chloroquine
Chloroquine
Chloroquine (USP/INN)
Chloroquine (VAN)
Chloroquine [USAN:INN:BAN]
Chloroquine Bis-Phosphoric Acid
Chloroquine phosphate
Chloroquine Phosphate
Chloroquine sulfate
Chloroquine sulphate
Chloroquinium
Chloroquinum
Chloroquinum [INN-Latin]
Chlorquin
CID2719
Cidanchin
Clorochina
Clorochina [DCIT]
Cloroquina
Cloroquina [INN-Spanish]
Cocartrit
CQ
CU-01000012392-2
D02366
Dawaquin
DB00608
Delagil
Dichinalex
DivK1c_000404
EINECS 200-191-2
Elestol
Gontochin
Gontochin phosphate
Heliopar
HMS2090O03
HSDB 3029
Hydroxychloroquine Sulfate
IDI1_000404
Imagon
|
Ipsen 225
Iroquine
KBio1_000404
KBio2_000592
KBio2_003160
KBio2_005728
KBio3_001221
KBioGR_000778
KBioSS_000592
Khingamin
Klorokin
Lapaquin
Lopac0_000296
LS-141726
Malaquin
Malaquin (*Diphosphate*)
Malaren
Malarex
Mesylith
Miniquine
MolMap_000009
MolPort-001-783-623
N(4)-(7-Chloro-4-quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine
N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine
N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine
N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine
NCGC00015256-04
NCGC00162120-01
nchembio.215-comp4
nchembio.368-comp8
nchembio.87-comp17
NCI60_000894
Neochin
NINDS_000404
Nivachine
Nivaquine
Nivaquine b
Nivaquine B
NSC 187208
NSC14050
NSC187208
Pfizerquine
Plaquenil
Prestwick0_000548
Prestwick1_000548
Prestwick2_000548
Prestwick3_000548
Quinachlor
Quinagamin
Quinagamine
Quinercyl
Quingamine
Quinilon
Quinoscan
Resochen
Resochin
Resoquina
Resoquine
Reumachlor
Reumaquin
Rivoquine
Ro 01-6014/N2
Ronaquine
Roquine
RP 3377
RP-3377
Sanoquin
Silbesan
Siragan
SMP2_000034
SN 6718
SN-7618
Solprina
Sopaquin
SPBio_000174
SPBio_002516
Spectrum_000132
Spectrum2_000127
Spectrum3_000341
Spectrum4_000279
Spectrum5_000707
ST 21
ST 21 (pharmaceutical)
Sulfate, chloroquine
Sulphate, chloroquine
Tanakan
Tanakene
Tresochin
Trochin
UNII-886U3H6UFF
W 7618
WIN 244
WLN: T66 BNJ EMY1&3N2&2 IG
|
|
| 8 |
|
Levoleucovorin |
Approved, Investigational |
Phase 4 |
|
68538-85-2 |
149436 |
|
Synonyms:
(6S)-5-Formyl-5,6,7,8-tetrahydrofolate
(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid
(6S)-5-Formyltetrahydrofolate
(6S)-5-formyltetrahydrofolic acid
(6S)-5-Formyltetrahydrofolic acid
(6S)-Folinate
(6S)-Folinic acid
(6S)-Leucovorin
(S)-Leucovorin
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formyl-(6S)-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
6 S Leucovorin
6S Leucovorin
6S-Leucovorin
6-S-Leucovorin
Acid, folinic
ácido levofolínico
Calcium folinate
Calcium leucovorin
CF
Citrovorum factor
Factor, citrovorum
Folinate
Folinate, calcium
Folinic acid
Folinic acid SF
Folinic acid-SF
Fusilev
Kunyrin
Leucoverin
|
Leucovorin
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, (S)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, (S)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monopotassium salt, (S)-isomer
Leucovorin, monosodium salt
Leucovorin, monosodium salt, (S)-isomer
Leukovorin
Leukovorum
Levo leucovorin
Levofolene
Levofolinate
Levofolinic acid
Levoleucovorin
Levo-leucovorin
L-Folinate
L-Folinic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamate
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolic acid
N5-Formyl-THF
Pteroyl-D-glutamate
S Leucovorin
S-Leucovorin
Welcovorin
Wellcovorin
|
|
| 9 |
|
Sulfadoxine |
Approved, Investigational |
Phase 4 |
|
2447-57-6 |
17134 |
|
Synonyms:
2447-57-6
46810_RIEDEL
4-Amino-N-(5,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide
4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide
4-amino-N-[5,6-bis(methyloxy)pyrimidin-4-yl]benzenesulfonamide
4-Sulfanilamido-5,6-dimethoxypyrimidine
4-Sulphanilamido-5,6-dimethoxypyrimidine
5-25-13-00306 (Beilstein Handbook Reference)
6-(4-Aminobenzenesulfonamido)-4,5-dimethoxypyrimidine
AB00514044
AC-11921
AC1L29DT
AC1Q46GG
Ambap2447-57-6
BPBio1_001286
BRD-K55250441-001-03-1
BRN 0625453
BSPBio_001168
C07630
CAS-2447-57-6
CHEBI:9329
CHEMBL1539
CID17134
D00580
DB01299
EINECS 219-504-9
Fanasil
Fanzil
HMS1571K10
HMS2090P07
HMS2094C19
I09-0529
LS-31247
MLS002154150
MolPort-003-850-341
N'-(5,6-Dimethoxy-4-pyrimidyl)sulfanilamide
N(sup 1)-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide
N1-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide
NCGC00016612-01
NCGC00016612-02
|
Orthosulfin
Prestwick0_001094
Prestwick1_001094
Prestwick2_001094
Prestwick3_001094
Ro 4-4393
Ro-4-4393
Roche brand OF sulfadoxine
S2511_Selleck
S7821_SIGMA
Sanasil: Sulfadoxine: Sulformetoxin
SMR000857259
Solfadossina
Solfadossina [DCIT]
SPBio_003054
Sulfadoxin
Sulfadoxina
Sulfadoxina [INN-Spanish]
Sulfadoxine
SULFADOXINE
Sulfadoxine (JAN/USP/INN)
Sulfadoxine [USAN:INN:BAN:JAN]
Sulfadoxine roche brand
Sulfadoxinum
Sulfadoxinum [INN-Latin]
Sulformethoxine
Sulformetoxine
Sulforthomidine
Sulphadoxina
Sulphadoxine
Sulphadoxinum
Sulphormethoxine
Sulphormetoxin
Sulphorthodimethoxine
Sulphorthomidine
UNII-88463U4SM5
WR 4073
WR 4873
ZINC00002094
|
|
| 10 |
|
Pyrimethamine |
Approved, Investigational, Vet_approved |
Phase 4 |
|
58-14-0 |
4993 |
|
Synonyms:
2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine
46706_FLUKA
46706_RIEDEL
4753 r.p
4753 R.P.
5-(4-chlorophenyl)-2,4-diamino-6-ethylpyrimidine
5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine
5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidi nediamine
5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine
5-(4-CHLOROPHENYL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE
5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine
5-(4-CHLORO-PHENYL)-6-ETHYL-PYRIMIDINE-2,4-DIAMINE
5-(p-chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
5-[4-Chlorophenyl]-6-ethyl-2,4-pyrimidinediamine
58-14-0
AB00052084
AC1L1JDI
AC-7879
AI3-25005
Aventis brand OF pyrimethamine
Aventis Brand of Pyrimethamine
AZT + Pyrimethamine combination
BIDD:GT0149
BIDD:PXR0173
BPBio1_000147
BRD-K88429204-001-05-4
BRN 0219864
BSPBio_000133
BSPBio_003282
BW 5063
BW 50-63
C07391
C12H13ClN4
CAS-58-14-0
CCRIS 546
CD
CHEBI:8673
CHEMBL36
Chloridin
Chloridine
Chloridyn
CID4993
CP6
CPD000058714
CRL-8131 & Pyrimethamine
CRL-8142 & Pyrimethamine
D00488
D011739
Darachlor
Daraclor
Darapram
Daraprim
Daraprim (TN)
Daraprime
Daraprin
DB00205
Diaminopyritamin
Disulone
DivK1c_000652
EINECS 200-364-2
Erbaprelina
Ethylpyrimidine
EXR-101
Fansidar
Fansidar (Pyrimethamine/Sulfadoxine)
Glaxo wellcome brand OF pyrimethamine
Glaxo Wellcome Brand of Pyrimethamine
GlaxoSmithKline brand OF pyrimethamine
GlaxoSmithKline Brand of Pyrimethamine
HMS1568G15
HMS1920N12
HMS2092E13
HMS502A14
IDI1_000652
KBio1_000652
KBio2_001386
KBio2_003954
KBio2_006522
|
KBio3_002502
KBioGR_001007
KBioSS_001386
Khloridin
L000713
Lactoferrin B & Pyrimethamine
Lactoferrin H & Pyrimethamine
LS-238
m alocid
Malacid
Malocid
Malocide
Maloprim
MCB-3837
MLS000028606
MLS001148621
MLS002454446
MLS002701881
MolPort-001-783-655
NCGC00016256-01
NCGC00016256-02
NCGC00023188-03
NCGC00023188-04
NCGC00023188-05
NCGC00023188-06
NCGC00023188-07
nchembio.215-comp13
nchembio.87-comp22
NCI60_002604
NCI-C01683
NCIOpen2_008313
NINDS_000652
NSC 3061
NSC3061
NSC-3061
Oxaquin
Pirimecidan
Pirimetamin
Pirimetamina
Pirimetamina [INN-Spanish]
Pirimetamina [Spanish]
Prestwick_504
Prestwick0_000037
Prestwick1_000037
Prestwick2_000037
Prestwick3_000037
Primethamine
Pyremethamine
Pyrimethamin
pyrimethamine
Pyrimethamine
Pyriméthamine
Pyrimethamine (JAN/USP/INN)
Pyrimethamine (Pyr)
Pyrimethamine [USAN:INN:BAN:JAN]
Pyrimethamine Hcl
Pyrimethaminum
Pyrimethaminum [INN-Latin]
RP 4753
S2006_Selleck
SAM002554921
SMR000058714
SPBio_000672
SPBio_002054
Spectrum_000906
SPECTRUM1500520
Spectrum2_000886
Spectrum3_001701
Spectrum4_000494
Spectrum5_001447
TCMDC-123831
TCMDC-125860
Tindurin
Tindurine
Tinduring
UNII-Z3614QOX8W
Wellcome brand OF pyrimethamine
Wellcome Brand of Pyrimethamine
WLN: T6N CNJ BZ DZ ER DG& F2
WR 2978
ZINC00057464
|
|
| 11 |
|
Mefloquine |
Approved, Investigational |
Phase 4 |
|
53230-10-7 |
4046 |
|
Synonyms:
(-)-(11S,2'R)-erythro-Mefloquine
(-)-Mefloquine
(-)-Threo-Mefloquine
(+)-(11R,2'S)-erythro-Mefloquine
(+)-Mefloquine
(+)-Threo-Mefloquine
(DL-erythro-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol
(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol
(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol
(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2R)-piperidin-2-yl]methanol
(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol
(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol
[(R*,S*)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol
[2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol
49752-90-1
51688-68-7
51742-87-1
51744-84-4
51744-85-5
53230-10-7
68682-27-9
a-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol
AB00052310
AC1L1HAJ
AC1L249S
AC1L9UO6
AC1MHD7J
AC1MHD7O
AC1Q4K1I
alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol
alpha-2-Piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol
AR-1G4597
BIDD:GT0596
BIDD:PXR0166
BPBio1_000190
BRD-A89585551-003-03-4
BSPBio_000172
C07633
C17H16F6N2O
CAS-51773-92-3
CHEBI:151162
CHEBI:403542
CHEMBL411329
CHEMBL411685
CHEMBL411686
CHEMBL416956
CID3000506
CID3000516
CID4046
CID40692
CID456309
D04895
DB00358
DivK1c_000790
EINECS 256-468-3
Erthro-.alpha.-[2-piperidyl]-2,8-bis[trifluoromethyl]-4-quinolinemethanol
HMS1922C09
HMS502H12
Hoffmann la roche brand OF mefloquine hydrochloride
Hoffmann-la roche brand OF mefloquine hydrochloride
HSDB 6853
IDI1_000790
KBio1_000790
KBio2_001792
KBio2_004360
KBio2_006928
KBio3_002046
|
KBioGR_001392
KBioSS_001792
Lariam
Lariam (Hydrochloride)
LS-142023
LS-187797
Mefloquin
Mefloquina
Mefloquina [INN-Spanish]
mefloquine
Mefloquine
Méfloquine
Mefloquine (USAN/INN)
Mefloquine [USAN:INN:BAN]
Mefloquine aziridine
Mefloquine HCL
Mefloquine hydrochloride
Mefloquinone
Mefloquinum
Mefloquinum [INN-Latin]
Mephloquine
MolPort-003-981-155
MQ
NCGC00016864-01
NCGC00094994-01
NCGC00094994-02
NCGC00094994-03
NCGC00094994-04
NCGC00161831-01
NCGC00161831-02
nchembio.215-comp3
nchembio.87-comp20
NINDS_000790
NSC157387
Prestwick0_000126
Prestwick1_000126
Prestwick2_000126
Prestwick3_000126
Racemic mefloquine
RO 13-7224
RO 13-7225
Ro 215998
Ro 21-5998
Ro 21-5998 (Hydrochloride)
Ro-21-5998-001
Roche brand OF mefloquine hydrochloride
RTI1169-1-1
RTI1172-1-1
RTI1173-1-1
RTI1174-1-1
RTI1188-1-1
RTI1189-1-1
SPB-80406
SPBio_001591
SPBio_002111
Spectrum_001312
SPECTRUM1503070
Spectrum2_001516
Spectrum3_000953
Spectrum4_001066
Spectrum5_001122
UNII-TML814419R
WR 142490
WR-142,490
WR-142490
WR-177,602
Α-2-piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol
|
|
| 12 |
|
Artemether |
Approved |
Phase 4 |
|
71963-77-4 |
119380 9796294 68911 |
|
Synonyms:
( )-alpha-Artemether
(1R,4S,5R,8S,9R,10S,12R,13R)-10-methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecane
(1R,4S,5R,8S,9R,10S,12R,13R)-10-Methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecane
(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12beta,12aR*)-isomer of artemether
(3r,5as,6r,8as,9r,10r,12r,12ar)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromene
(3R,5aS,6R,8aS,9R,10S,12R,12aR)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepine
(3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin
(5aS,6R,8aS,9R,10S,12R,12aR)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromene
.beta.-Artemether
.beta.-Dihydroartemisinin methyl ether
.beta.-Methylether of 11-epi-dihydroartemisinin
10-methoxy-1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane
10-Methoxy-1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane
159573-83-8
3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin, decahydro-10-methoxy-3,6,9-tri
71939-51-0
71963-77-4
74784-06-8
80286-56-2
93787-85-0
AC1L2APD
AC1L2XO8
AC1L9SH2
AC1L9UV0
AC1MI2ZX
AC1Q6Z74
AC1Q6Z7V
alpha-Artemether
alpha-Dihydroartemisinin methyl ether
AR-1A4424
Arteannuin ether
Artemetero
Artemetero [INN-Spanish]
Artemether
Artemether (INN)
Artemether [INN]
Artemether, (3R-(3alpha,5abeta,6alpha,8abeta,9alpha,10beta,12beta,12ar*))-isomer
Artemether, (3R-(3alpha,5abeta,6beta,8aalpha,9alpha,10beta,12beta,12ar*))-isomer
artemether, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,12aR*))-isomer
Artemether, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,12ar*))-isomer
artemether[inn]
Artemetheri
Artemetherum
Artemetherum [INN-Latin]
Artemisininelactol methyl ether
Artemos
Artenam
Artesaph
Artesian
Artimist
Artmether
b-Artemether
b-Dihydroartemisinin methyl ether
beta-Artemether
|
beta-Arthemeter
beta-Dihydroartemisinin methyl ether
BRN 5948416
C16H26O5
CHEBI:195280
CHEMBL411864
CHEMBL512315
CID10266705
CID104888
CID3062122
CID456408
CID500199
CID6483308
CID6712286
CID68911
CID9796294
CID9796295
CPD000469218
D02483
DB06697
dihydroartemisinin methyl ether
Dihydroartemisinin methyl ether
Dihydroqinghaosu methyl ether
Dihydroquinghaosu methyl ether
Falcidol
Gvither
HMS2052L09
HSDB 7456
I06-0205
KST-1A8041
LS-176935
LS-64237
Malartem
methyl-dihydroartemisinine
Methyl-dihydroartemisinine
MLS001424249
NCI60_022891
NSC 665970
NSC665970
O-Methyldihydroartemisinine
Paluther
rither
S2264_Selleck
SAM001246799
SM 224
SM 229
SM-224
SMR000469218
UNII-C7D6T3H22J
β-artemether
Î’-artemether
β-dihydroartemisinin methyl ether
Î’-dihydroartemisinin methyl ether
|
|
| 13 |
|
Lumefantrine |
Approved |
Phase 4 |
|
82186-77-4 |
6437380 |
|
Synonyms:
(+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-a-((dibutylamino)methyl)fluorene-4-methanol
(+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-alpha((dibutylamino)methyl)fluorene-4-methanol
(+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-alpha-((dibutylamino)methyl)fluorene-4-methanol
(+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-α-((dibutylamino)methyl)fluorene-4-methanol
(±)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-α-((dibutylamino)methyl)fluorene-4-methanol
120583-69-9
2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl]ethanol
2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]fluoren-4-yl]ethanol
2-Dibutylamino-1-[2,7-dichloro-9-(4-chloro-benzylidene)-9H-fluoren-4-yl]-ethanol
2-Dibutylamino-1-{2,7-dichloro-9-[1-(4-chloro-phenyl)-meth-(Z)-ylidene]-9H-fluoren-4-yl}-ethanol
82186-77-4
AC1O5NKD
AC-4542
benflumetol
Benflumetol
Benflumetol, (-)-isomer
Benflumetol, (+)-isomer
Benflumetol, (+-)-isomer
Bio-0132
|
C30H32Cl3NO
CHEBI:156095
CHEMBL38827
CID6437380
Coartem
D03821
DB06708
dl-Benflumelol
DL-Benflumelol
HSDB 7210
I14-7746
LS-177674
Lumefantrine
Lumefantrine (INN)
Lumefantrine [INN:BAN]
MolPort-006-394-826
NCGC00167490-01
UNII-F38R0JR742
|
|
| 14 |
|
Atovaquone |
Approved |
Phase 4 |
|
95233-18-4 |
74989 |
|
Synonyms:
2-(4-(4'-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
2-(4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
2-(trans-4-(p-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone
2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione
2-[trans-4-(p-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone
3-(4-(4-chlorophenyl)cyclohexyl)-4-hydroxy-naphthalene-1,2-dione
3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione
566C
566C80
566C80 hydroxynaphthoquinone
566C80, hydroxynaphthoquinone
94015-53-9
95233-18-4
AB00513855
AC-15237
AC1L2MZG
AC1Q6E9K
Acuvel
AR-1H7607
Atavaquone
ATO & IL-12
Atovacuona
Atovaquone
ATOVAQUONE
Atovaquone & Interleukin 12
Atovaquone (USP/INN)
Atovaquone [USAN:BAN:INN]
atovaquone GlaxoSmithKline brand
BIDD:GT0849
Bio-0115
BPBio1_000603
BSPBio_000547
BSPBio_002681
BW 556C-80
BW 566C
BW 566C80
BW 566C-80
BW-A 566C
C06835
C22H19ClO3
CAS-95233-18-4
CHEBI:478315
CHEBI:575568
CHEMBL1450
CID74989
Compound 566
CRL-8131 & Atovaquone
D00236
D053626
|
DB01117
DivK1c_006782
DRG-0084
FT-0081084
Glaxo Wellcome brand of atovaquone
GlaxoSmithKline brand of atovaquone
HMS1569L09
HMS1922F19
HMS2089M14
HMS2093C10
HSDB 7083
hydroxynaphthoquinone 566C80
hydroxynaphthoquinone, 566C80
I06-0872
KBio1_001726
KBio2_002223
KBio2_004791
KBio2_007359
KBio3_001901
KBioGR_001594
KBioSS_002223
LS-178256
Malarone Pediatric
Mepron
Mepron (antipneumocystic)
Mepron (TN)
MLS002153863
MolPort-003-666-542
MolPort-003-844-665
MolPort-006-666-289
NCGC00016961-01
NCGC00016961-02
NCGC00095113-01
NCGC00095113-02
Prestwick0_000534
Prestwick1_000534
Prestwick2_000534
Prestwick3_000534
pron
SMR001233220
SPBio_001849
SPBio_002468
SpecPlus_000686
Spectrum_001743
SPECTRUM1504210
Spectrum2_001665
Spectrum3_000991
Spectrum4_001117
Spectrum5_001382
STK636160
Wellvone
|
|
| 15 |
|
Proguanil |
Approved |
Phase 4 |
|
500-92-5 |
4923 |
|
Synonyms:
(1E)-1-[amino-(4-chloroanilino)methylidene]-2-propan-2-ylguanidine
(hydrochloride)
1-(p-Chlorophenyl)-5-isopropylbiguanide
1-Isopropyl-5-(4-chlorophenyl)biguanide
4-12-00-01198 (Beilstein Handbook Reference)
46920-30-3
500-92-5
637-32-1
637-32-1 (HYDROCHLORIDE)
AB00053776
AC1O1QGA
BIDD:GT0576
Bigumal
BPBio1_001207
BRD-K28183345-003-05-6
BRN 2811599
BSPBio_001097
BSPBio_003417
C11H16ClN5
CAS-637-32-1
CHEBI:8455
CHEMBL1377
Chlorguanid
Chlorguanide
Chloriguane
Chloroguanide
CID6178111
DB01131
Diguanyl (hydrochloride)
DivK1c_006763
Drinupal (hydrochloride)
EINECS 207-915-6
KBio1_001707
KBio2_002068
KBio2_004636
KBio2_007204
KBio3_002637
KBioGR_001204
KBioSS_002068
|
LS-43869
M-4888 (hydrochloride)
N-(4-Chlorophenyl)-N'-(1-methylethyl)imidodicarbonimidic diamide
N-(4-Chlorophenyl)-n'-(isopropyl)-imidodicarbonimidic diamide
N-(4-Chlorophenyl)-N'-(isopropyl)-imidodicarbonimidic diamide
N-(4-chlorophenyl)-N'-(propan-2-yl)imidodicarbonimidic diamide
N1-p-Chlorophenyl-N5-isopropylbiguanide
NCGC00016528-01
NCGC00016528-02
NCGC00016528-03
NSC12977
Paludrin
Paludrine (hydrochloride)
Palusil (hydrochloride)
Prestwick0_000999
Prestwick1_000999
Prestwick2_000999
Prestwick3_000999
proguanil
Proguanil
Proguanil [INN:BAN]
Proguanile
Proguanile [DCIT]
Proguanilo
Proguanilum
Proguanilum [INN-Latin]
RP-3359
SN-12837 (hydrochloride)
SPBio_001029
SPBio_002988
SpecPlus_000667
Spectrum_001588
Spectrum2_001135
Spectrum3_001659
Spectrum4_000622
Spectrum5_001384
Tirian (hydrochloride)
UNII-S61K3P7B2V
|
|
| 16 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
59-30-3 |
6037 |
|
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
ácido fólico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
AI3-26387
AKOS000503224
Antianemia factor
Apo-Folic
ARONIS014410
b9, Vitamin
BIDD:ER0563
BIDD:GT0641
BIF0608
bmse000299
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat b activ
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
Facid
Factor U
FOL
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
folic acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
|
Folipac
Folsaeure
Folsan
Folsaure
Folsäure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
Incafolic
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
Liver lactobacillus casei factor
Liver Lactobacillus casei factor
LS-2157
Millafol
Mission prenatal
Mittafol
MLS001304016
MLS001335861
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
nchembio.108-comp10
Nifolin
Nifolin [Denmark]
NINDS_000494
Novofolacid
Novofolacid [Canada]
N-Pteroyl-L-glutamate
N-pteroyl-L-glutamic acid
N-Pteroyl-L-glutamic acid
NSC 3073
PGA
PGA (VAN)
Prestwick_230
Prestwick3_000627
PteGlu
Pteroylglutamate
Pteroylglutamic acid
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
Serum Folate Level
SMP2_000137
SMR000471860
SPBio_001357
Spectrum_001381
SPECTRUM1502020
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin b9
Vitamin B9
Vitamin Bc
Vitamin BC
Vitamin be
Vitamin Be
Vitamin m
Vitamin M
|
|
| 17 |
|
Chlorproguanil |
Investigational |
Phase 4 |
|
537-21-3 |
151170 9571037 |
|
Synonyms:
1-(3,4-Dichlorophenyl)-5-isopropylbiguanide
15537-76-5 (unspecified hydrochloride)
537-21-3
6001-93-0 (mono-hydrochloride)
C11H15Cl2N5
CHEMBL1213553
Chlorproguanil
Chlorproguanil [INN:BAN]
Chlorproguanilum
Chlorproguanilum [INN-Latin]
CID9571037
|
Clorpreguanile
Clorpreguanile [DCIT]
Clorproguanil
Clorproguanil [INN-Spanish]
EINECS 208-660-3
Lapudrine
LS-175481
N-(3,4-dichlorophenyl)-N'-(1-methylethyl)imidodicarbonimidic diamide
UNII-8O3249M729
unspecified HCl of chlorproguanil
|
|
| 18 |
|
Dihydroartemisinin |
Experimental, Investigational |
Phase 4 |
|
71939-50-9 |
6918483 |
|
Synonyms:
(3R,5aS,6R,8aS,9R,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepin-10-ol
[3R-(3.alpha.,5a.beta.,6.beta.,8a.beta.,9.alpha.,10.alpha.,12.beta.,12aR*)]-Decahydro-10-hydroxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4.3-j]-1,2-benzodioxepin
1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol(Dihydroartemisinin)
71939-50-9
81496-81-3
AC1L32PY
AC1L9UV6
AC-2067
Ambotz71939-50-9
Artenimol
Artenimol (INN)
beta-Dihydroartemisinin
CHEBI:207229
CHEMBL25164
CID107770
|
CID456410
CID6918483
Cotecxin
D07362
D3793
Dihydroartemisinin
Dihydroartemisinine
Dihydroqinghaosu
Dihydroquinghaosu
Dihydroquinghoasu
GNF-PF-5634
JAV-110
LS-64240
VM3352
|
|
| 19 |
|
Piperaquine |
Experimental, Investigational |
Phase 4 |
|
4085-31-8 |
5079497 |
|
Synonyms:
1,3-bis(1-(7-chloro-4'-quinolyl)-4'-piperazinyl)propane
1,3-bis(4-(7'-chloro-4'-quinoline)-1-piperazine)
1,3-bis[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propane
4,4'-(propane-1,3-diyldipiperazine-4,1-diyl)bis(7-chloroquinoline)
4085-31-8
5-23-03-00072 (Beilstein Handbook Reference)
7-chloro-4-[4-[3-[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propyl]piperazin-1-yl]quinoline
83764-65-2
AC1L3UA1
AC1Q3T7B
AR-1F7471
BRN 0905079
|
C29H32Cl2N6
CHEMBL303933
CID122262
FT-0082661
I06-1673
LS-142194
piperaquine
Piperaquinoline
Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro- (9CI)
Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-)
ST51053186
|
|
| 20 |
|
Pyronaridine |
Investigational |
Phase 4 |
|
74847-35-1 |
5485198 |
|
Synonyms:
2-Methoxy-7-chloro-10-(3',5'-bis(pyrrolin-1-ylmethyl)-4'-hydroxyphenylamino)benzo(b)-1,5-naphthyridine
4-((7-Chloro-2-methoxybenzo(b)(1,5)naphthyridin-10-yl)amino)-2,6-bis((pyrrolidin-1-yl)methyl)phenol
4-((7-Chloro-2-methoxybenzo(b)-1,5-naphthyridin-10-yl)amino)-2,6-bis(1-pyrrolidinylmethyl)phenol
4-[(7-chloro-2-methoxy-1,5-dihydrobenzo[b][1,5]naphthyridin-10-yl)imino]-2,6-bis(pyrrolidin-1-ylmethyl)cyclohexa-2,5-dien-1-one
4-[(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol
74847-35-1
AC1NUNYW
Benzonaphthyridine 7351
C29H32ClN5O2
CHEMBL35228
CID5485198
|
LS-177158
Malaridine
MolPort-002-507-948
Phenol, 4-((7-chloro-2-methoxybenzo(b)-1,5-naphthyridin-10-yl)amino)-2,6-bis(1-pyrrolidinylmethyl)-, phosphate (1:4)
Pyronaridine
pyronaridine phosphate salt
Pyronaridine phosphate salt
Pyronaridine tetraphosphate
STK597795
STOCK5S-98760
|
|
| 21 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
| 22 |
|
Amebicides |
|
Phase 4 |
|
|
|
| 23 |
|
Antirheumatic Agents |
|
Phase 4 |
|
|
|
| 24 |
|
Analgesics, Non-Narcotic |
|
Phase 4 |
|
|
|
| 25 |
|
Red Cinchona |
|
Phase 4 |
|
|
|
| 26 |
|
Analgesics |
|
Phase 4 |
|
|
|
| 27 |
|
Anti-Retroviral Agents |
|
Phase 4 |
|
|
|
| 28 |
|
Pharmaceutical Solutions |
|
Phase 4 |
|
|
|
| 29 |
|
Antimetabolites |
|
Phase 4 |
|
|
|
| 30 |
|
Atovaquone, proguanil drug combination |
|
Phase 4 |
|
|
|
| 31 |
|
Chloroquine diphosphate |
|
Phase 4 |
|
50-63-5 |
|
| 32 |
|
Folic Acid Antagonists |
|
Phase 4 |
|
|
|
| 33 |
|
Artemisinine |
|
Phase 4 |
|
|
|
| 34 |
|
Vitamin B Complex |
|
Phase 4 |
|
|
|
| 35 |
|
Artemisinins |
|
Phase 4 |
|
|
|
| 36 |
|
Vitamin B9 |
|
Phase 4 |
|
|
|
| 37 |
|
Fanasil, pyrimethamine drug combination |
|
Phase 4 |
|
|
|
| 38 |
|
Folate |
|
Phase 4 |
|
|
|
| 39 |
|
Artemether, Lumefantrine Drug Combination |
|
Phase 4 |
|
|
|
| 40 |
|
Amoxicillin |
Approved, Vet_approved |
Phase 3 |
|
26787-78-0 |
33613 |
|
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(p-Hydroxy-a-aminophenylacetamido)penicillanate
6-(p-Hydroxy-a-aminophenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanate
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-Hydroxy-α-aminophenylacetamido)penicillanate
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-(p-Hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9ci
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
a-Amino-p-hydroxybenzylpenicillin
AC-12263
AC1L1PY2
Actimoxi
Almodan
alpha-Amino-p-hydroxybenzylpenicillin
Ambap26787-78-0
AMC
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 cap 250MG
Amox 500 cap 500MG
Amox S 125 sus 125mg/5ML
Amox S 250 sus 250mg/5ML
Amoxi
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
amoxicillanyl
amoxicillin
Amoxicillin
Amoxicillin (anhydrous)
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin clariana brand
AMOXICILLIN CRYSTALLINE
Amoxicillin monopotassium salt
Amoxicillin monosodium salt
Amoxicillin pediatric
AMOXICILLIN PEDIATRIC
Amoxicillin sodium
Amoxicillin trihydrate
Amoxicillin Trihydrate
Amoxicillin(usan)
Amoxicillin, (r*)-isomer
Amoxicilline
Amoxicilline [INN]
Amoxicilline [INN-French]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxi-mast
Amoxi-Mast
Amoxivet
Amoxycilin
Amoxycillin
Amoxycillin trihydrate
Amoxycillin Trihydrate
Amoxycillin, ban
Amoxymed
AMPC
Amrit
Anemolin
Anhydrous, amoxicillin
Apo-amoxi
Apo-Amoxi
Apo-amoxi cap 250MG
Apo-amoxi cap 500MG
Apo-amoxi PWR for susp 125mg/5ML
Apo-amoxi PWR for susp 250mg/5ML
Apo-amoxi sugar free
Aspenil
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN es-600
AX
Biomox
BLP 1410
BL-P 1410
|
BPBio1_000499
BRD-K55044200-001-03-9
Bristamox
BRL 2333
BRL-2333
BSPBio_000453
C06827
Cemoxin
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
Clamoxyl
Clamoxyl (SKB)
Clamoxyl g.a.
Clamoxyl parenteral
Clariana brand OF amoxicillin
CPD000058707
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D07452
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
DB01060
Delacillin
Dispermox
DisperMox
Efpenix
EINECS 248-003-8
Flemoxin
G.A., clamoxyl
Galenamox
Gen-amoxicillin 250MG
Gen-amoxicillin 500MG
Hiconcil
Histocillin
HMS1569G15
HSDB 3204
Hydroxyampicillin
Ibiamox
Imacillin
Lamoxy
Larotid
LS-149721
Metafarma capsules
Metifarma capsules
MLS000028632
MLS002222248
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
Novamoxin cap 250MG
Novamoxin cap 500MG
Novamoxin sus 125mg/5ML
Novamoxin sus 250mg/5ML
NSC 277174
NSC277174
Nu-amoxi cap 250MG
Nu-amoxi cap 500MG
Nu-amoxi sus 125/5ML
Nu-amoxi sus 250mg/5ML
Ospamox
Pamoxicillin
Parenteral, clamoxyl
Penamox
Pfizer brand OF amoxicillin sodium salt
PHL-Amoxicillin
p-Hydroxyampicillin
Piramox
PMS-Amoxicillin
Polymox
Prestwick_713
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prevpac
Pro amox PWR for oral susp 125mg/5ML
Pro amox-250 cap 250MG
Pro amox-500 cap 500MG
Pro-amox-250 orl sus 250mg/5ML
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
Sauracillin
Sawamox PM
SmithKline beecham brand OF amoxicillin sodium salt
SMR000058707
Sodium, amoxicillin
SPBio_002374
Sumox
Tolodina
Trihydrate, amoxicillin
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
α-amino-p-hydroxybenzylpenicillin
Α-amino-p-hydroxybenzylpenicillin
|
|
| 41 |
|
Acetaminophen |
Approved |
Phase 3 |
|
103-90-2 |
1983 |
|
Synonyms:
4-(Acetylamino)phenol
4-acetamidophenol
4-Acetamidophenol
4-Acetaminophenol
4'-hydroxyacetanilide
4'-Hydroxyacetanilide
4-Hydroxyacetanilide
4-Hydroxyanilid kyseliny octove
A.F. anacin
Abenol
Abensanil
Abrol
Abrolet
AC1Q1KYJ
AC1Q1KYK
Acamol
Accu-tap
Accu-Tap
Acenol
Acephen
Acertol
Aceta elixir
Aceta Elixir
Aceta tablets
Aceta Tablets
Acetaco
Acetagesic
Acetalgin
Acetamidophenol
Acetaminofen
Acetaminofén
Acetaminophen uniserts
Acetaminophene
Acétaminophène
Acetamol
Acetavance
Acetofen
Acetominophen
Actamin
Actamin extra
Actamin super
Actifed plus
Actifed Plus
Actimol
Actimol chewable tablets
Actimol children's suspension
Actimol infants' suspension
Actimol junior strength caplets
Actron
Afebrin
Afebryl
Aferadol
Algesidal
Algina
Algomol
Algotropyl
Allay
alpha-Per
Alpiny
Alpinyl
Alvedon
Amadil
Aminofen
Aminofen max
Anacin
Anacin 3
Anacin3
Anacin-3
Anacin-3 extra strength
Anadin dla dzieci
Anaflon
Analter
Anapap
Andox
Anelix
Anexsia
Anexsia 10/660
Anexsia 5/325
Anexsia 7.5/325
Anexsia 7.5/650
Anhiba
Anoquan
Anti-algos
Antidol
Anuphen
Apacet
Apacet capsules
Apacet elixir
Apacet extra strength caplets
Apacet extra strength tablets
Apacet regular strength tablets
Apadon
Apamid
Apamide
APAP
a-Per
A-Per
Apitrelal
Apo-acetaminophen
Arfen
Arthralgen
Asetam
Asomal
Aspac
Aspirin free anacin maximum strength caplets
Aspirin free anacin maximum strength gel caplets
Aspirin free anacin maximum strength tablets
Aspirin-free anacin
Aspirin-free excedrin caplets
Asplin
Atasol
Atasol caplets
Atasol drops
Atasol forte caplets
Atasol forte tablets
Atasol oral solution
Atasol tablets
Atralidon
Babikan
Bacetamol
Bancap
Bancap HC
Banesin
Bayer Select
Bayer select allergy-sinus
Bayer select head cold
Bayer select headache pain
Bayer select maximum strength headache pain relief formula
Bayer select menstrual multi-symptom
Bayer select sinus pain relief
Benmyo
Ben-u-ron
Bickie-mol
Biocetamol
Bucet
Butalbital
Butapap
Cadafen
Calapol
Calmanticold
Calonal
Calpol
Capital
Capital with codeine
Captin
Causalon
CCRIS 3
Cefalex
Cetadol
CHEBI:46195
Children'S acetaminophen elixir drops
Children'S acetaminophen oral solution
Children'S tylenol chewable
Claradol codeine
Clixodyne
Codabrol
COD-Acamol forte
Codalgin
Codapane
Codicet
Codisal
Codisal forte
Codoliprane
Codral pain relief
Cofamol
Co-Gesic
CO-Gesic
Conacetol
Contac cough & sore throat formula
Contra-schmerz p
Coricidin
Coricidin D
Coricidin sinus
Cosutone
Croix blanche
Cuponol
Curadon
Curpol
Custodial
D oliprane
Dafalgan
Dapa
Dapa X-S
Darocet
Darvocet
Darvocet-N 50
Datril
Datril extra-strength
Daygrip
Demilets
Deminofen
Democyl
Demogripal
Desfebre
Dhamol
DHC Plus
Dial-a-gesic
Dial-alpha-gesic
Dimindol
Dirox
Disprol
Dolcor
Dolefin
Dolegrippin
Dolene ap-65
Dolene AP-65
Dolgesic
Doliprane
Dolko
Dolofugin
Doloreduct
Dolorfug
Dolorol forte
Dolorstop
Dolotec
Dolprone
Dol-stop
Dorocoff
Dresan
Dristan cold no drowsiness
Dristancito
Drixoral Plus
Duaneo
Dularin
Duorol
Duracetamol
Duradyne DHC
Durapan
Dymadon
Dymadon co
Dymadon Co
Dymadon forte
Dypap
Ecosetol
Elixodyne
Empracet
Endecon
Enelfa
Eneril
Esgic
Esgic-plus
Eu-med
Eu-Med
Excedrin
Excedrin caplets
Excedrin extra strength caplets
Excipain
Exdol
Exdol strong
Fanalgic
Farmadol
Febranine
Febrectal
Febrectol
Febrex
Febricet
Febridol
Febrilix
Febrin
Febrinol
Febro-gesic
Febro-Gesic
Febrolin
Femcet
Fendon
Fensum
Fepanil
Fever All
Feverall
Feverall junior strength
Feverall sprinkle caps junior strength
Fevor
Finimal
Finiweh
Fioricet
Fluparmol
Fortalidon p
Fortalidon P
Freka-cetamol
Gattaphen T
Gelocatil
Geluprane
Genapap
Genapap children's elixir
Genapap children's tablets
Genapap extra strength caplets
Genapap extra strength tablets
Genapap regular strength tablets
Genebs
Genebs extra strength caplets
Genebs regular strength tablets
Genebs X-tra
Geralgine-p
Geralgine-P
Gripin bebe
Gripin Bebe
Grippostad
Gynospasmine
Hedex
Helon N
Homoolan
Hycomine compound
Hydrocet
Hydroxyacetanilide
Hy-phen
Hy-Phen
Ildamol
Inalgex
Infadrops
Infants' feverall
Influbene N
Injectapap
Intensin
Janupap
Jin Gang
Junior disprol
Kataprin
KBio1_000660
Kinder finimal
Korum
Kratofin simplex
L024125
Labamol
Lekadol
Lemgrip
Lemsip
Lestemp
Liqiprine
Liquagesic
Liquigesic co
Liquiprin
Liquiprin children's elixir
Liquiprin infants" drops
Lonarid
Lonarid mono
Lonarid Mono
Lorcet-HD
Lortab
Lupocet
Lyteca
Lyteca syrup
Lyteca Syrup
Magnidol
Malex N
Malgis
Malidens
Maxadol
Medigesic plus
Medinol paediatric
Medocodene
Melabon infantil
Mexalen
Midol maximum strength
Midol PM night time formula
Midol regular strength
Midol teen formula
Migraleve yellow
Minafen
|
Minoset
Miralgin
Momentum
mono Praecimed
Multin
N-(4-Hydroxyphenyl)acetamide
N-(4-Hydroxyphenyl)acetanilide
N-Acetyl-4-aminophenol
N-acetyl-p-aminophenol
N-Acetyl-p-aminophenol
Naldegesic
NAPA
Napafen
Napap
Naprinol
NCX 701
Nealgyl
Nebs
NEBS
NeoCitran
Neodol
Neodolito
Neo-fepramol
Neo-Fepramol
Neopap
Neotrend
Neuridon
New cortal for children
NilnOcen
Nina
Nobedon
Nodolex
NO-Febril
Noral
Norcet
Norco
NSC3991
O-Acetaminophenol
Ofirmev
Oltyl
Oralgan
Oraphen-PD
Ortensan
Oxycet
Oxycocet
Oxycodone 2.5/apap 500
Oxycodone 5/apap 500
p-(Acetylamino)phenol
Paceco
Pacemo
Pacemol
Pacet
p-acetamidophenol
p-Acetamidophenol
p-acetaminophenol
p-Acetaminophenol
p-Acetylaminophenol
Pacimol
Paedialgon
Paedol
Painex
Paldesic
Pamol
Panacete
Panadeine
Panadeine co
Panadeine Co
Panadiene
Panado-co
Panado-Co
Panado-co caplets
Panadol
Panadol extra strength
Panadol junior strength caplets
Panadol maximum strength caplets
Panadol maximum strength tablets
Panale ve
Panaleve
Panamax
Panasorb
Panasorbe
Panets
Panex
Panodil
Panofen
Pantalgin
Papa-Deine
Papa-deine #3
Papa-deine #4
Paracemol
Paracenol
Paracet
Paracetamol
Paracétamol
Paracetamol al
Paracetamol antipanin p
Paracetamol basics
Paracetamol BC
Paracetamol DC
Paracetamol dr. schmidgall
Paracetamol fecofar
Paracetamol genericon
Paracetamol hanseler
Paracetamol harkley
Paracetamol heumann
Paracetamol hexal
Paracetamol italfarmaco
Paracetamol nycomed
Paracetamol PB
Paracetamol raffo
Paracetamol ratiopharm
Paracetamol rosch
Paracetamol saar
Paracetamol smithkline beecham
Paracetamol stada
Paracetamol von CT
Paracetamol winthrop
Paracetamole
Paracetamolo
Paracetamolum
Paracetanol
Paracetol
Paracin
Paracod
Paracodol
Parador
Paradrops
Parakapton
Parake
Paralen
Paralief
Paralink
Paralyoc
Paramol
Paramolan
Paranox
Parapan
Parasedol
Parasin
Paraspen
Para-suppo
Para-Suppo
Para-tabs
Parcetol
Parelan
Parmol
Parogal
Paroma
Pasolind
Pasolind N
PCM Paracetamol lichtenstein
Pediapirin
Pediatrix
Pedric
Percocet
Percocet-5
Percocet-demi
Percogesic with codeine
Perdolan mono
Perfalgan
Pe-tam
Pe-Tam
Phenaphen
Phenaphen caplets
Phenaphen Caplets
Phenaphen w/codeine
Phendon
Phenipirin
Phogoglandin
Phrenilin
Phrenilin forte
Phrenilin Forte
p-hydroxy-acetanilid
p-hydroxyacetanilide
p-Hydroxyacetanilide
p-hydroxyphenolacetamide
p-Hydroxyphenolacetamide
Pinex
Piramin
Pirinasol
Plicet
Polmofen
Predimol
Predualito
Prestwick_13
Prodol
Prompt
Prontina
Propacet
Propacet 100
Proval #3
Puernol
Pulmofen
Pyregesic-C
Pyrigesic
Pyrinazine
Pyromed
Quiet world
Redutemp
Reliv
Remedol
Rhinex D-lay tablets
Rivalgyl
Robigesic
Robitussin night relief
Rockamol plus
Rounox
Roxicet
Roxicet 5/500
Roxilox
RubieMol
Rubophen
Rupemol
Salzone
Sanicet
Sanicopyrine
Scanol
Scentalgyl
Scherzatabletten rezeptur 534
Schmerzex
Sedalito
Sedapap
Semolacin
Servigesic
Seskamol
Setakop
Setamol
Setol
Sifenol
Sinaspril
Sinedol
Sine-OFF sinus medicine caplets
Sinmol
Sinubid
SK-Apap
Snaplets-FR
Spalt fur die nacht
Spalt N
SPBio_002836
ST Joseph aspirin-free
ST Joseph aspirin-free for children
St. joseph cold tablets for children
St. joseph fever reducer
St. Joseph Fever Reducer
Stanback
Stopain
Sudafed severe cold formula
Sudafed sinus
Sunetheton
Supac
Supadol mono
Supofen
Suppap
Suppap-120
Suppap-325
Suppap-650
Supramol-m
Supramol-M
Synalgos-Dc-A
Synalgos-DC-a
Tabalgin
Tachiprina
Talacen
Tapanol
Tapanol extra strength caplets
Tapanol extra strength tablets
Tapar
Tavist allergy/sinus/headache
Tavist Allergy/Sinus/Headache
Tazamol
Temlo
Tempanal
Tempra
Tempra caplets
Tempra chewable tablets
Tempra d.s
Tempra drops
Tempra syrup
Tencon
Termacet
Termalgin
Termalgine
Termofren
TheraFlu
Tibinide
Tibizide
Tiffy
Tisin
Tisiodrazida
Titralgan
Tizide
Tocris-1706
Toximer p
Toximer P
Tralgon
Treupel mon
Treupel N
Treuphadol
Triad
Triaminic sore throat formula
Triaprin
Tricoton
Tussapap
Ty lenol
Tycolet
TYL
Tylenol
Tylenol (TN)
Tylenol allergy sinus
Tylenol arthritis extended relief
Tylenol caplets
Tylenol children's chewable tablets
Tylenol children's elixir
Tylenol children's suspension liquid
Tylenol drops
Tylenol elixir
Tylenol extra strength adult liquid pain reliever
Tylenol extra strength caplets
Tylenol extra strength gelcaps
Tylenol extra strength tablets
Tylenol gelcaps
Tylenol infants drops
Tylenol infants" suspension drops
Tylenol junior strength caplets
Tylenol junior strength chewable tablets
Tylenol regular strength caplets
Tylenol regular strength tablets
Tylenol tablets
Tylex
Tylex CD
Tylol
Tylox
Tylox-325
Tymol
Ultracet
Upsanol
Utragin
Valadol
Valgesic
Valorin
Valorin extra
Valorin Extra
Vanquish
Veralgina
Vermidon
Verpol
Viclor richet
Vicodin
Vicodin es
Vicodin HP
Vips
Viruflu
Vivimed
Volpan
Wygesic
Zatinol
Zolben
|
|
| 42 |
|
Sulfalene |
|
Phase 3 |
|
|
|
| 43 |
|
Antibiotics, Antitubercular |
|
Phase 3 |
|
|
|
| 44 |
|
Antipyretics |
|
Phase 3 |
|
|
|
| 45 |
|
Etidronic acid |
Approved |
Phase 2 |
|
2809-21-4, 7414-83-7 |
3305 |
|
Synonyms:
(1-hydroxy-1-phosphonoethyl)phosphonic acid
(1-hydroxyethane-1,1-diyl)bis(phosphonic acid)
(1-Hydroxyethylene)diphosphonate
(1-Hydroxyethylene)diphosphonic acid
(1-Hydroxyethylene)diphosphonic acid, tetrapotassium salt
(1-Hydroxyethylidene)bis(phosphonate)
(1-Hydroxyethylidene)bis(phosphonic acid)
(1-Hydroxyethylidene)bisphosphonate
(1-Hydroxyethylidene)bisphosphonic acid
(1-Hydroxyethylidene)diphoshonic acid
(1-Hydroxyethylidene)diphosphonate
(1-hydroxy-ethylidene)diphosphonic acid
(1-Hydroxyethylidene)diphosphonic acid
(Hydroxyethylidene)diphosphonate
(Hydroxyethylidene)diphosphonic acid
0-02-00-00171 (Beilstein Handbook Reference)
1 Hydroxyethane 1,1 diphosphonate
1 Hydroxyethylidene 1,1 bisphosphonate
1,1 Hydroxyethylenediphosphonate
1,1,1-Ethanetriol diphosphonate
1,1,1-Ethanetriol diphosphonic acid
1,1-Hydroxyethylenediphosphonate
1000SL
100511-44-2
103736-66-9
106908-76-3
129130-42-3
138360-84-6
14860-53-8 (tetra-potassium salt)
192526-55-9
1-Hydroxy-1,1-diphosphonoethane
1-HYDROXY-1,1-DIPHOSPHONOETHANE
1-hydroxyethane 1,1-diphosphonic acid
1-Hydroxyethane-1,1,-diphosphonic acid
1-Hydroxyethane-1,1-bisphosphonate
1-Hydroxyethane-1,1-bisphosphonic acid
1-Hydroxyethane-1,1-diphosphonate
1-Hydroxyethane-1,1-diphosphonic acid
1-Hydroxyethanediphosphonate
1-Hydroxyethanediphosphonic acid
1-Hydroxyethylene diphosphonate, disodium
1-Hydroxyethylidene 1,1-diphosphonic acid
1-Hydroxyethylidene-1,1-biphosphonate
1-Hydroxyethylidene-1,1-bisphosphonate
1-Hydroxyethylidene-1,1-bisphosphonic acid
1-Hydroxyethylidene-1,1-diphosphonate
1-Hydroxyethylidene-1,1-diphosphonic acid
1-Hydroxyethylidenediphosphonic acid
2809-21-4
303177-33-5
51888-66-5
54342_ALDRICH
54342_FLUKA
66216-98-6
853028-38-3
85985-26-8
86159-18-4
AC1L1FMT
Acetodiphosphonate
Acetodiphosphonic acid
Acide etidronique
acide étidronique
Acide etidronique [INN-French]
Acido etidronico
ácido etidrónico
Acido etidronico [INN-Spanish]
acidum etidronicum
Acidum etidronicum
Acidum etidronicum [INN-Latin]
Bio-0708
BPBio1_000997
BRN 1789291
BSPBio_000905
C07736
CHEBI:170675
CHEBI:4907
CHEMBL871
CID3305
Cintichem Technetium 99m Hedspa
D02373
|
DB01077
Dequest 2010
Dequest 2015
Dequest Z 010
Dicalcium ehdp
Dicalcium etidronate
Didronel
Didronel IV
Diphosphonate (base)
Diphosphonate, disodium 1-hydroxyethylene
Diphosphonic acid, hydroxyethylidene
Disodium 1 hydroxyethylene diphosphonate
Disodium 1-hydroxyethylene diphosphonate
Disodium etidronate
EHDP
EHDP, dicalcium
EINECS 220-552-8
Ethane-1-hydroxy-1,1-bisphosphonate
ethane-1-hydroxy-1,1-bisphosphonic acid
Ethane-1-hydroxy-1,1-bisphosphonic acid
Ethane-1-hydroxy-1,1-diphosphonate
Ethane-1-hydroxy-1,1-diphosphonic acid
Ethanehydroxydiphosphonate
Ethanehydroxyphosphate
etidronate
Etidronate
Etidronate disodium
Etidronate Disodium
Etidronate, dicalcium
Etidronate, disodium
Etidronate, sodium
Etidronate, tetrapotassium salt
Etidronic acid
Etidronic acid (USAN/INN)
Etidronic acid [USAN:INN:BAN]
Etidronic acid monohydrate
Etidronsaeure
Etidronsäure
Ferrofos 510
H0587
H6773_ALDRICH
H6773_SIGMA
HEDP
HEDSPA
HSDB 5898
Hydroxyethane-1,1-diphosphonic acid
Hydroxyethanediphosphonate
Hydroxyethanediphosphonic acid
Hydroxyethylidene diphosphonic acid
I14-1271
Jsp005415
LS-106637
MLS002207267
MLS002695948
MolPort-001-786-542
MPI Stannous Diphosphonate
NCGC00159352-02
NSC 227995
NSC227995
Osteoscan
Oxyethylidenediphosphonate
Oxyethylidenediphosphonic acid
Phosphonic acid, (1-hydroxyethylidene)bis-, disodium salt
Phosphonic acid, 1-hydroxy-1,1-ethanediyl ester
Prestwick0_000863
Prestwick1_000863
Prestwick2_000863
Prestwick3_000863
RP 61
Salt etidronate, tetrapotassium
SMR000038750
Sodium etidronate
SPBio_002826
STK721995
Tetrapotassium salt etidronate
Turpinal SL
UNII-M2F465ROXU
Xidifon
Xidiphon
Xydiphone
|
|
| 46 |
|
Methylene blue |
Approved, Investigational |
Phase 2 |
|
61-73-4 |
|
|
Synonyms:
aniline violet
Azul de metileno
Basic Blue 9
C.I. basic blue 9
Chlorure de méthylthioninium
Cloruro de metiltioninio
Lowacryl blue 9
Methylene blue
Methylene blue anhydrous
Methylenium ceruleum
|
methylthionine chloride
Methylthioninii chloridum
methylthioninium chloride
Methylthioninium chloride
methylthioninium chloride Proveblue
Solvent blue 8
Swiss blue
tetrametylthionine chloride
Urolene Blue
|
|
| 47 |
|
Aluminum hydroxide |
Approved, Investigational |
Phase 1, Phase 2 |
|
21645-51-2 |
|
|
Synonyms:
Aluminio hidróxido
Aluminium hydroxide
Aluminium hydroxide gel, dried
Aluminium hydroxide, dried
|
Aluminum hydroxide gel, dried
Aluminum hydroxide, dried
Dried aluminium hydroxide
Dried aluminum hydroxide gel
|
|
| 48 |
|
Rosiglitazone |
Approved, Investigational |
Phase 1, Phase 2 |
|
122320-73-4 |
77999 |
|
Synonyms:
(±)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione
(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion
[3H]rosiglitazone
122320-73-4
2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- (9CI)
5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
5-((4-(2-(Methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate
5-(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione
5-[[4-[2-(methyl-(2-pyridyl)amino)ethoxy]phenyl]methyl] thiazolidine-2,4-dione
5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
AC1L2U9N
AC-3459
Avandia
BRD-A97437073-001-02-3
BRD-A97437073-001-03-1
Brl 49653
Brl-49653
BRL49653
BRL-49653
BSPBio_002693
C18H19N3O3S
CID77999
D08491
DB00412
Gaudil
Gaudil (TN)
Glaxo wellcome brand OF rosiglitazone maleate
GlaxoSmithKline brand OF rosiglitazone maleate
HMS1922J11
HMS2094O13
HSDB 7555
I06-0141
IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin)
KBio2_002183
KBio2_004751
KBio2_007319
|
KBio3_001913
KBioGR_001609
KBioSS_002183
LS-151340
MolPort-002-508-212
NCGC00095124-01
NCGC00095124-02
NCGC00095124-03
RGZ
Rosi
Rosigilitazone
Rosigliazone maleate
Rosiglitazon
rosiglitazona
Rosiglitazona
rosiglitazone
Rosiglitazone
rosiglitazone (Avandia)
Rosiglitazone (INN)
Rosiglitazone [INN:BAN]
Rosiglitazone maleate
rosiglitazonum
Rosiglitazonum
Rosiglizole
RSG
S00306
SmithKline beecham brand OF rosiglitazone maleate
SPBio_001142
Spectrum_001703
SPECTRUM1504263
Spectrum2_001241
Spectrum3_000997
Spectrum4_001125
Spectrum5_001464
STOCK6S-23924
TDZ 01
UNII-05V02F2KDG
|
|
| 49 |
|
tafenoquine |
Approved, Investigational |
Phase 2 |
|
106635-80-7 |
115358 |
|
Synonyms:
|
| 50 |
|
Ganciclovir |
Approved, Investigational |
Phase 1, Phase 2 |
|
82410-32-0 |
3454 |
|
Synonyms:
106931-35-5
107910-75-8 (mono-hydrochloride salt)
2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol
2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one
2-Amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one
2-Amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol
2-Amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol
2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one
2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one
2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone
2-Amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone
2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one
2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one
2'-NDG
2'-Nor-2'-deoxyguanosine
82410-32-0
86357-12-2
9-((1,3-Dihydroxy-2-propoxy)methyl)guanine
9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine
9-(1,3-DIHYDROXY-propoxymethane)guanine
9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE
9-[(1,3-dihydroxy-2-propoxy)methyl]guanine
9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine
96551-29-0
AC-12604
AC1L1FZ2
AC1Q52OB
AKOS004119898
BB_NC-1042
BIDD:GT0783
Biolf 62
BIOLF-62
BPBio1_000877
BSPBio_000797
BW 759
BW 759U
BW-759U
BW-795
BW-B 759U
CAS-82410-32-0
CCRIS 9212
CHEBI:465284
CHEMBL182
CID3454
Citovirax
CPD000058324
Cymevan
Cymeven
Cymevene
Cytovene
Cytovene (TN)
Cytovene-IV
D00333
DB01004
DRG-0018
EU-0100539
G 2536
|
G2536_SIGMA
GA2
ganciclovir
Ganciclovir
Ganciclovir & C34-dgA immunotoxin
Ganciclovir & D5-dgA immunotoxin
Ganciclovir (JAN/USP/INN)
Ganciclovir [USAN:INN:BAN:JAN]
Ganciclovir sodium
GANCICLOVIR SODIUM
Ganciclovir, monosodium salt
Ganciclovirum
Ganciclovirum [Latin]
Gancyclovir
GCV & 1110U81
GCV & MSL
Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)- and MSL, neutralizing monoclonal antibody
HHEMG
HMS1570H19
HMS2090K08
HSDB 6512
Hydroxyacyclovir
I07-0010
IN1478
Lopac0_000539
Lopac-G-2536
LS-73939
MB3795
MLS000028481
MLS001077349
MolPort-000-758-398
MolPort-002-507-301
NCGC00015471-01
NCGC00015471-02
NCGC00015471-03
NCGC00015471-06
NCGC00093928-01
NCGC00093928-02
NCGC00168567-01
nchembio.87-comp3
PDSP1_000816
PDSP2_000803
Prestwick_1068
Prestwick0_000839
Prestwick1_000839
Prestwick2_000839
Prestwick3_000839
RS-21592
SAM002548936
SMP2_000038
SMR000058324
SPBio_002718
ST-605
STK801910
UNII-P9G3CKZ4P5
Virgan
Vitrasert
Vitrasert (TN)
ZINC00001505
Zirgan
|
|
Interventional clinical trials:
(show top 50)
(show all 342)
| # |
Name |
Status |
NCT ID |
Phase |
Drugs |
| 1 |
Comparing the Effectiveness of 5 Artemisinin Combination Treatment Regimens in the Treatment of Uncomplicated Falciparum Malaria |
Unknown status |
NCT00902811 |
Phase 4 |
AM(FDC);AM(LT);AL;DP;AA(FDC) |
| 2 |
Efficacy of Artesunate Monotherapy and Dihydroartemisinin - Piperaquine in Patients With Uncomplicated Falciparum Malaria in Central Vietnam |
Unknown status |
NCT02604966 |
Phase 4 |
Artesunate (AS) group;DHA - PPQ group |
| 3 |
Programmatic Implementation of ACTs in Malawi: Safety and Effectiveness of Combination Therapies With Repeated Treatments for Uncomplicated P. Falciparum Malaria Over a Three-year Period |
Unknown status |
NCT01038063 |
Phase 4 |
Artemether-lumefantrine combination |
| 4 |
Dihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in Sudan |
Unknown status |
NCT01075945 |
Phase 4 |
Dihydroartemisinin- piperaquine;artemether- lumefantrine |
| 5 |
Artemether/ Lumefantrine: A Study of the Effect of Local Food on Pharmacokinetics of Lumefantrine and Population Pharmacokinetics of Lumefantrine Among Ugandan Children |
Unknown status |
NCT01944189 |
Phase 4 |
|
| 6 |
Assessment of in Vivo and in Vitro Efficacy of Combined Artesunate/Mefloquine Therapy for Treatment of Uncomplicated Plasmodium Falciparum Infection in the Peruvian Amazon |
Unknown status |
NCT02084602 |
Phase 4 |
Artesunate;Mefloquine |
| 7 |
Impact of Insecticide Resistance in Anopheles Arabiensis on the Effectiveness of Malaria Vector Control in Sudan |
Unknown status |
NCT01713517 |
Phase 4 |
|
| 8 |
A Randomized, Double Blind Trial on the Efficacy and Safety of Amodiaquine-Artesunate and Amodiaquine Alone in the Treatment of Children With Uncomplicated Falciparum Malaria |
Unknown status |
NCT00238017 |
Phase 4 |
amodiaquine-artesunate versus amodiaquine |
| 9 |
A Double-blind Randomised Trial to Assess the Tolerability of Amodiaquine Plus Artesunate (AQ-Art) Versus Chlorproguanil Plus Dapsone Plus Artesunate (CDA) in the Treatment of Uncomplicated P. Falciparum Malaria in Malawi |
Completed |
NCT00164359 |
Phase 4 |
Amodiaquine plus artesunate;chlorproguanil-dapsone plus artesunate |
| 10 |
Study of Therapeutic Efficacy, Safety and Pharmacokinetic Interactions Between Artemether-lumefantrine and Nevirapine-based Antiretrovirals in HIV-infected Patients With Uncomplicated Falciparum-malaria in Muheza, Northeastern Tanzania |
Completed |
NCT00885287 |
Phase 4 |
Artemether-lumefantrine (AL) |
| 11 |
Randomized Study of the Tolerability and Efficacy of Artemether-Lumefantrine Versus Artesunate Plus Amodiaquine Coadministered for the Treatment of Uncomplicated Falciparum Malaria in Zanzibar |
Completed |
NCT03764527 |
Phase 4 |
Artemether-lumefantrine;Coadministered Artesunate plus Amodiaquine |
| 12 |
A Multicentre Randomised Comparative Clinical Trial of the Efficacy of Artesunate + Amodiaquine Versus Artemether-lumefantrine (Coartem®) for the Treatment of Uncomplicated Childhood Plasmodium Falciparum Malaria in Zanzibar |
Completed |
NCT03768908 |
Phase 4 |
Artemether-lumefantrine;Artesunate + Amodiaquine |
| 13 |
Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Five Years After Wide Scale Use of the Drug in Tanzania. |
Completed |
NCT02089841 |
Phase 4 |
Artemether-lumefantrine |
| 14 |
Rapid Diagnostic Testing and Artemisinin-Based Combination Therapy for Uncomplicated Malaria by Community Health Workers |
Completed |
NCT00301015 |
Phase 4 |
|
| 15 |
Assessing the Effectiveness of Targeted Active Case Detection Among High Risk Populations in Southern Lao PDR |
Completed |
NCT03783299 |
Phase 4 |
Artemether-lumefantrine;Primaquine Phosphate |
| 16 |
Efficacy and Safety of Artesunate + Amodiaquine Combined With a Single Low Dose of Primaquine (0.25 mg/kg) for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Zanzibar |
Completed |
NCT03773536 |
Phase 4 |
Artesunate-amodiaquine given with single low dose primaquine |
| 17 |
In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated Plasmodium Falciparum Malaria in Malawi, 2014 |
Completed |
NCT02637128 |
Phase 4 |
artemether-lumefantrine (AL);artesunate-amodiaquine (ASAQ) |
| 18 |
Clinical Efficacy of Artemisinin-based Combination Therapy for Treatment of Uncomplicated Plasmodium Falciparum Malaria in North Sumatera, Indonesia and the Association of Molecular Markers With Treatment Outcomes |
Completed |
NCT02325180 |
Phase 4 |
Dihydroartemisinin-Piperaquine;Artemether-lumefantrine |
| 19 |
A Randomized Open-Label Trial of the Efficacy of Artemether-Lumefantrine Suspension Compared With Artemether-Lumefantrine Tablets for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Less Than Five Years in Western Kenya |
Completed |
NCT00529867 |
Phase 4 |
Artemether/lumefantrine tablets;Artemether/Lumefantrine suspension |
| 20 |
A Randomized Study to Compare Artesunate + Amiodaquine Versus Artemether + Lumefantrine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks Occurring During 2 Years in a Cohort in Senegal |
Completed |
NCT00540410 |
Phase 4 |
Coarsucam® (artésunate (AS) + amodiaquine (AQ) as fixed dose combination);Coartem® (arthemether+ lumefantrine) |
| 21 |
Efficacy of Artesunate-amodiaquine, Dihydroartemisinin-piperaquine and Artemether-lumefantrine Combination Therapies for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Aged 6 to 59 Months in Maradi, Niger 2012-13 |
Completed |
NCT01755559 |
Phase 4 |
Artesunate-amodiaquine;Dihydroartemisinin-piperaquine;Artemether-lumefantrine |
| 22 |
A Randomised Study to Compare a Fixed Dose Combination of Artesunate Plus Amiodaquine (Coarsucam) Versus a Fixed Dose Combination of Artemether Plus Lumefantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks Occurring During the 2 Years of Follow-up, in Children in Uganda. |
Completed |
NCT00699920 |
Phase 4 |
Coarsucam;Coartem |
| 23 |
Efficacy of Amodiaquine-artesunate in the Treatment of Symptomatic, Uncomplicated Plasmodium Falciparum Malaria Among 6-59 Month Old Children at an IPTi Site in Rural Western Kenya |
Completed |
NCT00425763 |
Phase 4 |
AQAS |
| 24 |
Clinical Trial of Extended-dose Chloroquine Versus Standard Chloroquine Treatment for Resistant Falciparum Malaria Among Afghan Refugees in NWFP Pakistan |
Completed |
NCT01019408 |
Phase 4 |
Chloroquine |
| 25 |
Open-label, Multi-center, Non-comparative Efficacy, Safety, and Tolerability Study of Co-artemether in the Treatment of Acute Uncomplicated Malaria in Non-immune Patients |
Completed |
NCT00233337 |
Phase 4 |
Co-artemether |
| 26 |
Artemether-lumefantrine Vs Co-formulated Amodiaquine + Artesunate for the Treatment of Uncomplicated Falciparum Malaria: a Randomized Open-label Trial to Evaluate the Effectiveness of the Burkina Faso New Drug Policy |
Completed |
NCT01017770 |
Phase 4 |
Artesunate-amodiaquine;Artemether-lumefantrine |
| 27 |
A Multicentre, Randomised Trial to Detect in Vivo Resistance of Plasmodium Falciparum to Artesunate in Patients With Uncomplicated Malaria. |
Completed |
NCT01350856 |
Phase 4 |
Artesunate 2;Artesunate 4 |
| 28 |
A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects |
Completed |
NCT00859807 |
Phase 4 |
Flavoquine®, Camoquin® Suspension;Flavoquine®, Camoquin® Suspension |
| 29 |
Efficacy and Safety of Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Falciparum Malaria in Mainland Tanzania |
Completed |
NCT03431714 |
Phase 4 |
Artesunate amodiaquine |
| 30 |
Safety, Tolerability, Pharmacokinetics and Efficacy, Phase Iv, Open Label Study of Fixed Arco® and Eurartesim® Therapies in Adults and Children With Uncomplicated P. Falciparum Malaria in Tanzania |
Completed |
NCT01930331 |
Phase 4 |
artemisinin/naphthoquine;dihydroartemisinin/piperaquine phosphate |
| 31 |
Chloroquine and Sulfadoxine-Pyrimethamine Efficacy for the Treatment of Uncomplicated Falciparum Malaria in Blantyre, Malawi |
Completed |
NCT00125489 |
Phase 4 |
chloroquine sulfate;sulfadoxine/pyrimethamine |
| 32 |
A Nested Open Labeled Study to Compare the Effectiveness and Safety of a Fixed-dose Combination of Artesunate Plus Amodiaquine (ASAQ Winthrop®) in the Unsupervised Treatment of Uncomplicated Plasmodium Falciparum Malaria Attacks in Two Patient Groups Enrolled at Two Year-intervals in a Pilot District of Côte d'Ivoire |
Completed |
NCT01023399 |
Phase 4 |
Artesunate + Amodiaquine |
| 33 |
An Open-label, Randomized, Single-center, Parallel Group Study of the Effects of Artemether-lumefantrine (Coartem®) Atovaquone-proguanil (Malarone®) and Artesunate-mefloquine on Auditory Function Following the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Patients 12 Years of Age or Older |
Completed |
NCT00444106 |
Phase 4 |
Artesunate-mefloquine;Atovaquone-proguanil;Artemether-lumefantrine |
| 34 |
Randomised, Comparative Study of the Efficacy and Safety of Arsucam® Administered as a Single Daily Intake Versus Two Daily Intakes in the Treatment of Plasmodium Falciparum Malaria Attack |
Completed |
NCT00445796 |
Phase 4 |
Artesunate;Amodiaquine |
| 35 |
Short Course of Quinine Plus a Single Dose of Sulphadoxine-Pyrimethamine for Plasmodium Falciparum Malaria |
Completed |
NCT00167739 |
Phase 4 |
Quinine plus sulfadoxine-pyrimethamine |
| 36 |
Efficacy and Safety of Artesunate-amodiaquine, Artemether-lumefantrine and Dihydroartemisinine-piperaquine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Democratic Republic of Congo: a Randomized Controlled Trial |
Completed |
NCT02940756 |
Phase 4 |
artesunate-amodiaquine;artemether-lumefantrine;Dihydroartemisinine-piperaquine |
| 37 |
A Phase IV Study on the Safety and Effectiveness of a Fixed-dose Combination of Artesunate and Mefloquine (Artequin[TM] Paediatric) Administered for 3 Days in Children With Uncomplicated Plasmodium Falciparum Malaria in Africa |
Completed |
NCT00978172 |
Phase 4 |
artesunate and mefloquine |
| 38 |
The Efficacy of Re-treatment With Sulfadoxine-pyrimethamine in Children With Recrudescent Malaria in Guinea-Bissau |
Completed |
NCT00137553 |
Phase 4 |
Sulfadoxine-pyrimethamine (Fansidar) |
| 39 |
Chloroquine and Amodiaquine for Treatment of Symptomatic Children With Plasmodium Malaria in Guinea-Bissau |
Completed |
NCT00137514 |
Phase 4 |
chloroquine;amodiaquine |
| 40 |
Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea Bissau. |
Completed |
NCT00426439 |
Phase 4 |
Chloroquine;Artemether-lumefantrine (Coartem) |
| 41 |
An Open Randomised Trial of the Efficacy of Sulfadoxine-Pyrimethamine (SP), Amodiaquine + SP (AQ-SP), AQ + Artesunate (AQ-Art), Chlorproguanil-Dapsone + Art (CD-Art), and Lumefantrine-Artemether (LA) for Uncomplicated Malaria in Malawi |
Completed |
NCT00164710 |
Phase 4 |
sulfadoxine-pyrimethamine;amodiaquine plus sulfadoxine-pyrimethamine;amodiaquine plus artesunate;chlorproguanil-dapsone plus artesunate;lumefantrine-artemether |
| 42 |
"Aiming at Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in an Era of Imminent Plasmodium Falciparum Resistance in Bagamoyo District, Tanzania - New Strategies With Old Tools" |
Completed |
NCT03241901 |
Phase 4 |
Artemether-Lumefantrine Tab 20-120mg;Primaquine Phosphate 0.25 mg/kg |
| 43 |
Phase IIIb/IV Cohort Event Monitoring Study To Evaluate, In Real Life Setting, The Safety And Tolerability In Malaria Patients Of The Fixed-Dose Artemisinin-Based Combination Therapy Pyramax® |
Completed |
NCT03201770 |
Phase 4 |
pyronaridine artesunate |
| 44 |
The Tolerability and Safety of Low Dose Primaquine for Transmission Blocking in Symptomatic Falciparum Infected Cambodians |
Completed |
NCT02434952 |
Phase 4 |
Dihydroartemisinin piperaquine (DHA PP);Primaquine |
| 45 |
Enhancing Preventive Therapy of Malaria In Children With Sickle Cell Anemia in East Africa (EPiTOMISE) |
Completed |
NCT03178643 |
Phase 4 |
Proguanil Oral Tablet;Sulfadoxine/Pyrimethanine-Amodiaquine (SP-AQ);Dihydroartemisinin-Piperaquine (DP) |
| 46 |
An Examination of ACT Strategy in South-central Asia on Falciparum Malaria in a Context Where Vivax is the Major Species |
Completed |
NCT00935688 |
Phase 4 |
|
| 47 |
In Vivo Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Uncomplicated Falciparum Malaria: an Open-randomised, Non-inferiority Clinical Trial in South Kivu, DR Congo |
Completed |
NCT02741024 |
Phase 4 |
Amodiaquine-Artesunate (ASAQ);Artemether-Lumefantrine (AL) |
| 48 |
Monitoring the Efficacy of Dihydroartemisinin - Piperaquine in Patients With Uncomplicated Falciparum Malaria in Traleng Commune, Central Vietnam |
Completed |
NCT01775592 |
Phase 4 |
Arterakin (DHA-PPQ) |
| 49 |
In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate for the Treatment of Uncomplicated Falciparum Malaria in Children: A Multisite, Open-label, Two-cohort Clinical Trial in Mozambique. |
Completed |
NCT02168569 |
Phase 4 |
Coartemâ„¢ (Artemether-lumefantrine combination);Coarsucamâ„¢ (Amodiaquine-artesunate combination) |
| 50 |
In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate for the Treatment of Uncomplicated Falciparum Malaria in Children: A Multisite Open Label, Two-cohort Clinical Trial in Mozambique |
Completed |
NCT04370977 |
Phase 4 |
Coartemâ„¢ (Artemether-lumefantrine combination);Winthropâ„¢ (Amodiaquine-artesunate combination) |
Inferred drug relations via
UMLS
71
/
NDF-RT
51
:
|
Chloroquine
Chloroquine hydrochloride
chloroquine phosphate
halofantrine
Halofantrine hydrochloride
Mefloquine
Mefloquine Hydrochloride
Primaquine
Primaquine Phosphate
|
Proguanil
Pyrimethamine
Quinacrine
Quinacrine Monohydrochloride
Quinine
QUININE SO4 PWDR
Quinine Sulfate
Sulfadoxine
|
|
